Pharmagreen Biotech Inc. (PHBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0017
-0.0001 (6.25%)
Mar 9, 2026, 11:43 AM EST
Pharmagreen Biotech Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2017 |
| Revenue | 0 | 0 | 0 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -29.10% | 13.74% | - | - | - | - | Upgrade
|
| Cost of Revenue | 0 | 0 | 0 | - | - | - | Upgrade
|
| Gross Profit | 0 | 0 | 0 | - | - | - | Upgrade
|
| Selling, General & Admin | 0.24 | 0.25 | 0.47 | 1.07 | 0.75 | 0.49 | Upgrade
|
| Operating Expenses | 0.24 | 0.25 | 0.47 | 1.07 | 0.75 | 0.49 | Upgrade
|
| Operating Income | -0.23 | -0.25 | -0.47 | -1.07 | -0.75 | -0.49 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.12 | -0.05 | -0.77 | -0.67 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0 | 0 | -0.03 | 0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | -0.73 | 0 | 0.22 | -3.26 | -1.15 | Upgrade
|
| EBT Excluding Unusual Items | -0.23 | -1.01 | -0.59 | -0.93 | -4.77 | -2.31 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.43 | Upgrade
|
| Other Unusual Items | - | 0 | 0.02 | 0.06 | 0.24 | 0.26 | Upgrade
|
| Pretax Income | -0.23 | -1 | -0.57 | -0.88 | -4.53 | -2.48 | Upgrade
|
| Earnings From Continuing Operations | -0.23 | -1 | -0.57 | -0.88 | -4.53 | -2.48 | Upgrade
|
| Net Income to Company | -0.23 | -1 | -0.57 | -0.88 | -4.53 | -2.48 | Upgrade
|
| Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0.04 | Upgrade
|
| Net Income | -0.23 | -1 | -0.57 | -0.88 | -4.53 | -2.44 | Upgrade
|
| Net Income to Common | -0.23 | -1 | -0.57 | -0.88 | -4.53 | -2.44 | Upgrade
|
| Shares Outstanding (Basic) | 664 | 659 | 467 | 404 | 294 | 82 | Upgrade
|
| Shares Outstanding (Diluted) | 664 | 659 | 467 | 404 | 294 | 82 | Upgrade
|
| Shares Change (YoY) | 28.47% | 41.33% | 15.55% | 37.46% | 257.86% | 10.82% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 | -0.03 | Upgrade
|
| Free Cash Flow | -0.03 | -0.03 | -0.07 | -0.43 | -0.21 | -0.61 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | -0.00 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 44.90% | 50.91% | 31.02% | - | - | - | Upgrade
|
| Operating Margin | -7807.69% | -7278.06% | -15810.84% | - | - | - | Upgrade
|
| Profit Margin | -7536.88% | -29454.52% | -18971.82% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -1098.63% | -823.64% | -2462.91% | - | - | - | Upgrade
|
| EBIT | -0.23 | -0.25 | -0.47 | -1.07 | -0.75 | -0.49 | Upgrade
|
| Advertising Expenses | - | 0.01 | 0.04 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.